Year |
Citation |
Score |
2023 |
Moutafi M, Robbins CJ, Yaghoobi V, Fernandez AI, Martinez-Morilla S, Xirou V, Bai Y, Song Y, Gaule P, Krueger J, Bloom K, Hill S, Liebler DC, Fulton R, Rimm DL. Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1101-1108. PMID 36775350 DOI: 10.1038/s41374-022-00804-9 |
0.398 |
|
2022 |
Moutafi M, Robbins CJ, Yaghoobi V, Fernandez AI, Martinez-Morilla S, Xirou V, Bai Y, Song Y, Gaule P, Krueger J, Bloom K, Hill S, Liebler DC, Fulton R, Rimm DL. Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1101-1108. PMID 35595825 DOI: 10.1038/s41374-022-00804-9 |
0.398 |
|
2022 |
Moutafi M, Robbins CJ, Yaghoobi V, Fernandez AI, Martinez-Morilla S, Xirou V, Bai Y, Song Y, Gaule P, Krueger J, Bloom K, Hill S, Liebler DC, Fulton R, Rimm DL. Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1101-1108. PMID 35595825 DOI: 10.1038/s41374-022-00804-9 |
0.398 |
|
2016 |
Weber MR, Zuka M, Lorger M, Tschan M, Torbett BE, Zijlstra A, Quigley JP, Staflin K, Eliceiri BP, Krueger JS, Marchese P, Ruggeri ZM, Felding BH. Activated tumor cell integrin αvβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream. Thrombosis Research. 140: S27-36. PMID 27067975 DOI: 10.1016/S0049-3848(16)30095-0 |
0.442 |
|
2012 |
Potts SJ, Krueger JS, Landis ND, Eberhard DA, Young GD, Schmechel SC, Lange H. Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 1342-57. PMID 22801299 DOI: 10.1038/Labinvest.2012.91 |
0.332 |
|
2011 |
Argast GM, Krueger JS, Thomson S, Sujka-Kwok I, Carey K, Silva S, O'Connor M, Mercado P, Mulford IJ, Young GD, Sennello R, Wild R, Pachter JA, Kan JL, Haley J, et al. Inducible expression of TGFβ, snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model. Clinical & Experimental Metastasis. 28: 593-614. PMID 21643654 DOI: 10.1007/s10585-011-9394-8 |
0.441 |
|
2010 |
Staflin K, Krueger JS, Hachmann J, Forsyth JS, Lorger M, Steiniger SC, Mee J, Pop C, Salvesen GS, Janda KD, Felding-Habermann B. Targeting activated integrin alphavbeta3 with patient-derived antibodies impacts late-stage multiorgan metastasis. Clinical & Experimental Metastasis. 27: 217-31. PMID 20225083 DOI: 10.1007/S10585-010-9320-5 |
0.386 |
|
2009 |
Katz J, Krueger J, Felding-Habermann B, Snyder EY. Maintaining and engineering neural stem cells for delivery of genetically encoded therapy to brain tumors. Methods in Molecular Biology (Clifton, N.J.). 568: 249-59. PMID 19582432 DOI: 10.1007/978-1-59745-280-9_16 |
0.354 |
|
2009 |
Lorger M, Krueger JS, O'Neal M, Staflin K, Felding-Habermann B. Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain. Proceedings of the National Academy of Sciences of the United States of America. 106: 10666-71. PMID 19541645 DOI: 10.1073/Pnas.0903035106 |
0.363 |
|
2007 |
Glading A, Koziol JA, Krueger J, Ginsberg MH. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Research. 67: 1536-44. PMID 17308092 DOI: 10.1158/0008-5472.Can-06-1378 |
0.606 |
|
2007 |
Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR, Felding-Habermann B. Adaptation of energy metabolism in breast cancer brain metastases. Cancer Research. 67: 1472-86. PMID 17308085 DOI: 10.1158/0008-5472.CAN-06-3137 |
0.426 |
|
2005 |
Krueger J, Chou FL, Glading A, Schaefer E, Ginsberg MH. Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Molecular Biology of the Cell. 16: 3552-61. PMID 15917297 DOI: 10.1091/Mbc.E04-11-1007 |
0.464 |
|
2002 |
Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. Oncogene. 21: 4000-8. PMID 12037682 DOI: 10.1038/Sj.Onc.1205506 |
0.506 |
|
2001 |
Krueger JS, Keshamouni VG, Atanaskova N, Reddy KB. Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion. Oncogene. 20: 4209-18. PMID 11464287 DOI: 10.1038/Sj.Onc.1204541 |
0.51 |
|
1999 |
Reddy KB, Krueger JS, Kondapaka SB, Diglio CA. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. International Journal of Cancer. 82: 268-73. PMID 10389762 DOI: 10.1002/(Sici)1097-0215(19990719)82:2<268::Aid-Ijc18>3.0.Co;2-4 |
0.735 |
|
Show low-probability matches. |